Modra Murovska

Modra Murovska, MD, PhD, (b. 1949) is a researcher in virology, medical microbiology, and molecular biology; the Director of The Institute of Microbiology and Virology, Riga Stradins University, Riga, Latvia; and an Associate Professor at Riga Stradins University, Riga, Latvia. She is a member of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME).

In 2009-2012, Dr. Murovska was assigned as Principle Investigator for the Latvian Council of Science in the investigation of etiopathogenesis of chronic fatigue syndrome, post-infection and unspecified origin encephalopathy and elaboration of diagnostic criterions.

EUROMENE
Dr. Murovska chairs the Management Committee of EUROMENE, a European Union not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and was the impetus to the program being started.

International Consensus Criteria
Dr. Murovska is one of the authors of the 2011 case definition, International Consensus Criteria.

Education

 * 1972, MD, Riga Medical Institute /Medical Academy of Latvia/ (Faculty of Pediatrics)
 * 1978, Dr.med. (Candidate of Science in former USSR system, Ph.D. in Western countries), Cancer Research Centre, USSR Academy of Medical Sciences, Moscow, Russia

Notable studies

 * 2006, Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome
 * 2012, Association of active human herpesvirus-6, -7 and parvovirus B19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
 * 2014, No evidence of XMRV provirus sequences in patients with myalgic encephalomyelitis/chronic fatigue syndrome and individuals with unspecified encephalopathy (Full Text)
 * 2014, Assessment of Value of Fatigue Severity and Symptoms in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Fibromyalgia (Full text)
 * 2016, Occurrence, phase and status of human parvovirus B19 infection in patients with myalgic encephalomyelitis/chronic fatigue syndrome (Abstract)
 * 2017, The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE (Full Text)
 * 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease (Full Text)
 * 2018, Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review (Full text)
 * 2018, Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Full text)
 * 2019, PSY44 Economic Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to Patients: Comparative Study
 * 2020, Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology - (Full text)
 * 2020, Cytomegalovirus, Epstein‐Barr virus, and human herpesvirus‐6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome - (Full text)
 * 2020, Prediction of Discontinuation of Structured Exercise Programme in Chronic Fatigue Syndrome Patient - (Full text)
 * 2021, Relationship between cardiopulmonary, mitochondrial and autonomic nervous system function improvement after an individualised activity programme upon Chronic Fatigue Syndrome patients - (Full text)
 * 2021, European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe - (Full text)

Online presence

 * Pubmed for Modra Murovska
 * Latvian Scientists webpage